GeneDx Holdings
WGS
45.46
-3.78
-7.68%
GeneDx Holdings
US · WGS
#2702 by market cap
Listed 1970
45.46
-3.78
-7.68%
Periodic snapshot; not a real-time feed.
· 2026-11-20 19:30
Recent news
-
Rating change
Piper Sandler Maintains GeneDx Holdings(WGS.US) With Buy Rating, Cuts Target Price to $63Market Newswire · 2026/6/23
-
GUIDANCE: (WGS) GeneDx Holdings Corp. Expects Q4 Revenue $135.0MMT Newswires · 2026/11/10
-
Rating change
Craig-Hallum Maintains GeneDx Holdings(WGS.US) With Buy Rating, Announces Target Price $85Market Newswire · 2026/5/5
-
Rating change
Wells Fargo Maintains GeneDx Holdings(WGS.US) With Buy Rating, Maintains Target Price $75Market Newswire · 2026/7/30
-
Rating change
Jefferies Maintains GeneDx Holdings(WGS.US) With Buy Rating, Cuts Target Price to $100Market Newswire · 2026/5/27
-
Rating change
Guggenheim Maintains GeneDx Holdings(WGS.US) With Buy Rating, Maintains Target Price $83Market Newswire · 2026/11/10
-
Craig-Hallum Maintains GeneDx Holdings(WGS.US) With Buy Rating, Cuts Target Price to $66Market Newswire · 2026/11/13
-
Piper Sandler Maintains GeneDx Holdings(WGS.US) With Buy Rating, Raises Target Price to $95Market Newswire · 2026/11/10
-
Rating change
A Quick Look at Today's Ratings for GeneDx Holdings(WGS.US), With a Forecast Between $75 to $103Market Newswire · 2026/8/5
-
Rating change
TD Cowen Maintains GeneDx Holdings(WGS.US) With Buy Rating, Cuts Target Price to $85Market Newswire · 2026/7/16
-
Rating change
A Quick Look at Today's Ratings for GeneDx Holdings(WGS.US), With a Forecast Between $70 to $130Market Newswire · 2026/5/5
-
Company notice
GeneDx Holdings: GeneDx Holdings Corporation - Reverse Split Option Symbol: WGS New Symbol: WGS1OCC · 2023/5/3
-
Rating change
BTIG Maintains GeneDx Holdings(WGS.US) With Buy Rating, Maintains Target Price $90Market Newswire · 2026/7/23
-
Rating change
Craig-Hallum Maintains GeneDx Holdings(WGS.US) With Buy RatingMarket Newswire · 2026/6/10
-
Rating change
Craig-Hallum Maintains GeneDx Holdings(WGS.US) With Buy Rating, Maintains Target Price $85Market Newswire · 2026/5/14
-
CCORF Maintains GeneDx Holdings(WGS.US) With Buy Rating, Maintains Target Price $90Market Newswire · 2026/11/10
-
BTIG Maintains GeneDx Holdings(WGS.US) With Buy Rating, Cuts Target Price to $85Market Newswire · 2026/11/10
-
Rating change
Guggenheim Maintains GeneDx Holdings(WGS.US) With Buy Rating, Raises Target Price to $74Market Newswire · 2026/6/29
-
Rating change
Guggenheim Maintains GeneDx Holdings(WGS.US) With Buy Rating, Raises Target Price to $83Market Newswire · 2026/10/1
-
Rating change
Craig-Hallum Maintains GeneDx Holdings(WGS.US) With Buy Rating, Maintains Target Price $103Market Newswire · 2026/9/23
-
Rating change
Piper Sandler Maintains GeneDx Holdings(WGS.US) With Buy Rating, Maintains Target Price $130Market Newswire · 2026/4/21
-
Rating change
Wells Fargo Maintains GeneDx Holdings(WGS.US) With Buy Rating, Maintains Target Price $155Market Newswire · 2026/2/25
-
Rating change
Craig-Hallum Maintains GeneDx Holdings(WGS.US) With Buy Rating, Announces Target Price $153Market Newswire · 2026/3/12
-
Rating change
Guggenheim Maintains GeneDx Holdings(WGS.US) With Buy Rating, Cuts Target Price to $100Market Newswire · 2026/3/30
-
Rating change
CCORF Maintains GeneDx Holdings(WGS.US) With Buy Rating, Cuts Target Price to $100Market Newswire · 2026/4/20
Headlines are aggregated automatically and are not independently verified or edited by our team.
Quote time 2026-11-20 19:30:06 · For reference only, not investment advice and not tailored to your situation.
GeneDx Holdings discussion 0 comments